{"id":47072,"date":"2024-03-18T09:17:26","date_gmt":"2024-03-18T09:17:26","guid":{"rendered":"https:\/?p=47072"},"modified":"2024-03-18T09:17:26","modified_gmt":"2024-03-18T09:17:26","slug":"meta-faces-legal-heat-over-alleged-drug-trade","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/meta-faces-legal-heat-over-alleged-drug-trade\/","title":{"rendered":"Meta Faces Legal Heat Over Alleged Drug Trade"},"content":{"rendered":"

Meta Platforms Inc (META: NSD<\/a><\/strong>) is now facing a new legal problem: federal authorities in the US are looking into whether it has any ties to the illegal drug trade, according to a report in the Wall Street Journal.\u00a0<\/span><\/p>\n

Federal prosecutors are focused on drug-related content on Meta’s social media sites, such as Facebook and Instagram. For their investigation into the chance of illegal drug sales going through these channels, they are looking for records.<\/span><\/p>\n

 <\/p>\n

Stock Target Advisor\u2019s Analysts on Meta:<\/strong><\/h2>\n

Considering the legal challenges, how does Meta fare from an investment perspective? According to Stock Target Advisor<\/a><\/strong>, Meta Platform ‘s stock warrants a ‘Buy’ rating. With a target price of $417.04, Meta is projected to witness a price change of -13.85% over the next twelve months.\u00a0<\/span><\/p>\n

Stock Target Advisor’s analysis reveals several positive signals from Meta, including superior risk-adjusted returns, a robust cash flow position, and high market capitalization. On the minus side, there are some potential pitfalls including overpricing.<\/span><\/p>\n

<\/p>\n

\n
\n

META Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n